ZEMBRACE SYMTOUCH (AUTOINJECTOR) FDA approval date
The FDA approved ZEMBRACE SYMTOUCH (AUTOINJECTOR) on 28 Jan 2016.
- FDA approval date
- 28 Jan 2016
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as SUMATRIPTAN SUCCINATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2016-01-28Day | ZEMBRACE SYMTOUCH (AUTOINJECTOR) | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208223", "applicant_as_listed_by_fda": "TONIX MEDS", "brand_names": ["ZEMBRACE SYMTOUCH (AUTOINJECTOR)"], "active_ingredients": ["SUMATRIPTAN SUCCINATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160128", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |